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We describe the emergence of serotype G12 rotavi-
ruses (67 [6.9%] of 971 specimens tested) among children 
hospitalized with rotavirus gastroenteritis in Hungary dur-
ing 2005. These ﬁ  ndings are consistent with recent reports 
of the possible global spread and increasing epidemiologic 
importance of these strains, which may have implications 
for current rotavirus vaccination strategies. 
G
roup A rotaviruses are the leading cause of acute se-
vere gastroenteritis in infants and young children 
worldwide. Approximately 130 million children are infect-
ed with rotavirus, and nearly 450,000–750,000 die of dis-
ease caused by this agent each year (1). Group A rotaviruses 
are classiﬁ  ed into G and P serotypes and genotypes on the 
basis of antigenic and genetic diversity of the outer capsid 
proteins, VP7 and VP4, respectively. At present, 11 of 15 
G types and 12 of 26 P types are known to infect humans. 
On a global basis, most severe infections are caused by 5 G 
types (G1–G4 and G9) and 3 P types (P1A[8], P1B[4], and 
P2A[6]), although considerable differences exist in some 
areas, especially in tropical countries (2,3).
One year after its introduction in 1998, RotaShield, the 
ﬁ  rst licensed rotavirus vaccine, was withdrawn from use 
due to an association with intussusception. Recently, 2 new 
candidate vaccines, RotaTeq and Rotarix, were licensed for 
use in >40 countries and introduced into the vaccine market 
of several nations. RotaTeq was developed with the aim of 
providing serotype-speciﬁ  c immunity against the 4 com-
mon G types (G1–G4) and 1 common P type (P1A[8]). In 
contrast, Rotarix vaccine, a monovalent vaccine containing 
a single P1A[8],G1 strain, is expected to induce heterotypic 
immunity to a variety of strains that have epidemiologic 
and clinical importance. However, the increasing number 
of reports of the emergence of novel G and P types in vari-
ous countries raises concerns about the adequacy of current 
vaccination strategies (2,3). Strain surveillance studies dur-
ing and after introduction of these vaccines are needed to 
gauge their impact on circulating strains and monitor for 
possible emergence of rotavirus types that escape the im-
munity provided by the vaccines.
As part of the Hungarian rotavirus strain surveillance 
program, we obtained fecal samples from community-ac-
quired rotavirus gastroenteritis patients <15 years of age 
who were admitted with acute dehydrating diarrhea in 
2005 to the “St. Laszlo” Hospital, Budapest. The rotavi-
rus-positive samples (conﬁ  rmed by use of an immunochro-
matographic assay with Rota Uni-Strip [Coris BioConcept, 
Gemblaux, Belgium]) were delivered to our laboratory on 
a monthly basis. Routine strain characterization included 
polyacrylamide gel electrophoresis of the viral genome 
(electropherotyping) and genotyping of the outer capsid 
genes, VP7 and VP4, by reverse transcription–PCR (RT-
PCR), as described previously (4). The G-typing algorithm 
included the use of 3 primer sets (speciﬁ  c for G1–G4, G6, 
and G9). In spite of the use of a variety of primer sets, 85 
(8.7%) of the 971 analyzed specimens were nontypeable 
G serotypes. A relatively high number of these untypeable 
strains (n = 67) had identical RNA patterns (long elec-
tropherotype; data not shown), which suggested that they 
might belong to the same serotype. To investigate this pos-
sibility, we sequenced a 501-bp stretch of the VP7 gene (nt 
79–579, amino acids [aa] 11–177) from 4 of these strains, 
using procedures we described elsewhere (4). These data 
showed that the 4 strains share 100% nt sequence identity 
to each other, >90% nt identity and 91% aa similarity to 
serotype G12 strains, and <78% similarity to other sero-
types, a ﬁ  nding that strongly suggested that they belonged 
to serotype G12 (data not shown).
To test the remaining G-nontypeable strains, we set 
up a genotype-speciﬁ  c RT-PCR assay, using a G12-spe-
ciﬁ  c primer designed by Samajdar et al. (5), homologous 
to the 4 sequenced strains, in combination with a consensus 
VP7 gene oligonucleotide, 9Con1, to yield an amplicon of 
464 bp. We ﬁ  rst tested the speciﬁ  city of this primer pair by 
using the Hungarian G12 strains conﬁ  rmed by nucleotide 
sequencing and a variety of other strains (including 8 G1, 
2 G2, 2 G3, 4 G4, 15 G9, and 4 untypeable strains) unre-
lated to the Hungarian G12 strains that were isolated during 
the same period. None of the non-G12 strains produced an 
amplicon after RT-PCR with this primer pair. In contrast, 
all 63 strains with the same electropherotype as the 4 se-
quenced G12 strains gave a 464-bp amplicon when tested 
with this primer pair, suggesting that they also belonged to 
G12. Including the 4 sequenced strains, the 67 G12 strains 
identiﬁ  ed represented 6.9% of all typeable by electrophere-
sis strains collected in the study period. Although most of 
the rotavirus gastroenteritis cases were identiﬁ  ed during 
the peak activity of group A rotaviruses (March–April), 
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the G12 strains also showed relative abundance in summer 
and autumn, representing 15%–28.6% of the total rotavirus 
strains detected during this period (Figure 1). The emer-
gence of these strains in Hungary during 2005 raises the 
question of whether they were able to overcome the im-
munity of older children or neonates to common rotavirus 
strains, as demonstrated earlier when serotype G9 rotavi-
ruses emerged in Europe. The mean and median ages of 
children infected with G12 rotaviruses (2.7 and 2.2 years, 
respectively) were, however, not signiﬁ  cantly  different 
from those of children infected with type G1 (3.0 and 2.5 
years, respectively), G2 (2.4 and 2.0 years, respectively), 
G4 (2.9 and 2.4 years, respectively), and G9 (2.9 and 2.3 
years, respectively) rotaviruses. Only children infected 
with G3 and G6 rotaviruses showed signiﬁ  cant differences 
in mean and median ages compared with those for children 
with G12 rotavirus (G3: 4.8 and 3.8 years, respectively, 
p = 0.009; G6: 5.3 and 4.3 years, respectively, p = 0.047). 
A subset of G12 samples subjected to P genotyping (n = 
14) tested positive for P[8]; this result was conﬁ  rmed by se-
quencing results for 3 strains. No other RNA patterns were 
associated with G12 speciﬁ  city.
The ﬁ  rst description of G12 rotaviruses dates back to 
the 1990s, when 2 unusual human strains (L26 and L27) 
from the Philippines were characterized serologically and 
by nucleotide sequencing as P[4],G12 with subgroup I 
speciﬁ  city and a long electropherotype (6,7). The origin 
of these strains was obscure because they were apparently 
very rare in humans over the next 10 years and had not been 
previously detected in animals. Beginning in 2002, reports 
of the detection and increased prevalence of G12 strains 
have appeared from Asia (Thailand, India, Korea, Japan, 
Bangladesh, Nepal, and Saudi Arabia) and the Americas 
(the United States, Argentina, and Brazil) (5,8–14), includ-
ing strains with as yet unpublished G12 VP7 sequences in 
the GenBank database. Although these strains are closely 
related to each other (>96.9% nt identity), they have di-
verged substantially from early human G12 isolates (<91% 
nt identity).
While the origin of G12 strains is unknown, a G12 
rotavirus was recently identiﬁ  ed in a pig, representing a 
possible animal source of this serotype (15). However, this 
single porcine isolate was not highly related to any known 
human G12 isolate (<92% nt identity), a ﬁ  nding that leaves 
gaps in our knowledge about the source of the modern lin-
eages of serotype G12 rotaviruses from humans.
The global emergence of rotavirus G12 shares several 
features with the worldwide spread of serotype G9 in the 
mid to late 1990s (2,3). First, both serotypes were identiﬁ  ed 
in humans ≈2 decades ago and subsequently were rarely de-
tected for many years despite intensiﬁ  ed surveillance activ-
ity and the introduction of sensitive and speciﬁ  c molecular 
typing methods. Second, sequence analysis and serologic 
studies demonstrated substantial genetic and antigenic dif-
ferences between early and modern variants within both 
serotypes, which suggested a new or separate introduction 
into humans. Third, of these coexisting genetic lineages, 
only 1, the modern lineage of each serotype, has been 
recognized as being capable of spreading globally. Four, 
various associated P types have been detected and display 
geographic differences in their distribution. For example, 
G12 strains in South America and far eastern Asia contain 
the globally rare P[9]; the only identiﬁ  ed G12 strain in the 
United States bears the regionally common P[6]; Hungar-
ian strains are associated with the most common genotype, 
P[8]; and Indian strains have been found in association with 
globally or regionally distributed P[4], P[6], or P[8] speci-
ﬁ  cities. It will be interesting to determine, whether, as with 
the spread of G9 strains (3), emergence of G12 rotavirus 
will occur predominantly through reassortment of a single 
gene, VP7, into a background of globally common human 
Wa genogroup strains, as suggested by our ﬁ  nding of G12 
in Hungarian P[8] strains with a typical long electrophero-
type. Last, identiﬁ  cation of clearly related VP7 genes in 
pigs suggests that we should continue to search for possible 
ancestors for both serotypes in the porcine species. This 
ﬁ  nding also reafﬁ  rms that pigs act as reservoirs of newly 
recognized human rotavirus antigenic types.
At the time of manuscript preparation, ≈40 G12 VP7 
sequences were available in the DNA databases. Most se-
quence data have been published from India, where G12 
strains showing minor genetic variation in their VP7 gene 
sequences (<3% nt difference) were isolated between 2001 
and 2005 in various geographic regions. In contrast, all 4 
Hungarian G12 strains share 100% sequence identity over 
a stretch of 501 nt. This ﬁ  nding suggests that G12 rotavi-
ruses circulated for some years in India before their iden-
Figure 1. Temporal distribution of serotype G12 human rotaviruses 
in Budapest, Hungary, 2005. Black columns indicate the number 
(N) of strains identiﬁ  ed; gray columns represent the percentage of 
total strains for each month that were type G1. DISPATCHES
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tiﬁ  cation. By contrast, the G12 rotavirus detected in 2005 
in Hungary is likely the result of a very recent introduction. 
One possibility is the importation of a single G12 strain 
into Hungary, which subsequently spread in the population. 
Although few data are available on the sequence of P[8] 
VP4 genes of G12 strains, we found that the P[8] VP4 of 
the Hungarian G12 strains was most closely related to the 
VP4 of a Saudi Arabian strain, MD844 (>99.4% nt simi-
larity along with corresponding sequence length), conﬁ  rm-
ing the epidemiologic linkage among these strains that was 
suggested by the nearly complete sequence identity for the 
VP7 gene (>99.4%, Figure 2).
Detailed molecular characterization of the entire ge-
nome is needed to help determine the extent of genetic vari-
ation and the relatedness of these Hungarian G12 strains to 
other, recently emerged G12 rotaviruses. More intensiﬁ  ed 
investigation of animal rotavirus strains may identify the 
possible animal ancestor of the new genetic lineage. Con-
tinuous monitoring of human rotavirus strains circulating in 
local communities will be important to determine if we are 
again detecting the early stages of the global emergence of 
a novel genetic lineage of an “old” rotavirus serotype. This 
was seen several years ago for the global spread of a mod-
ern lineage of serotype G9 rotaviruses. This ﬁ  nding may 
have important implications for vaccine use in planned or 
already launched rotavirus immunization programs in nu-
merous countries worldwide.
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